This website uses cookies to ensure you get the best experience on our website.

Biocrucible and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking "Manage cookies" at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor
Biocrucible
Picture of Giorgio Morello

Giorgio Morello

Lead Scientist – Research & Development

Giorgio Morello is a Lead Scientist at Biocrucible. After receiving his PhD in Bioinorganic Chemistry at the University of Oxford, he gained industry experience with Johnson Matthey (Cambridge, UK) and ATDBio (Oxford, UK) working as a biocatalysis researcher and senior scientist. He acquired a diverse and interdisciplinary range of expertise encompassing bioelectrochemistry, bioinorganic chemistry, oligonucleotide synthesis and biocatalysis. Giorgio has authored publications in leading scientific journals and received a BSc and MSc in Biotechnology from the University of Milan-Bicocca and a PhD from the University of Oxford.

Some of my colleagues

Picture of LFrigotto
LFrigotto
Emma Williams
Lateral Flow Scientist
Picture of Hannah Williams
Hannah Williams
Picture of Mike Haggis-Powell
Mike Haggis-Powell
Lead Scientist

About Biocrucible

Biocrucible, a Sapphiros group company aims to develop proprietary molecular detection technologies deploying ultra-rapid isothermal nucleic acid amplification that enable near-patient and at-home testing for infectious disease or genetic indications.

 

    Founded in 2021

    Already working at Biocrucible?

    Let’s recruit together and find your next colleague.

    @biocrucible.co.uk